ZYPREXA class action claim launched in Alberta

action in the Court of Queen's Bench of Alberta against Eli Lilly & Company and Eli Lilly Canada Inc., the makers and distributors of Zyprexa, for damages ...

TORONTO, Feb. 18 /CNW/ - The firm of Stevensons Barristers is pleased to announce that it has commenced a class action in the Court of Queen's Bench of Alberta against Eli Lilly & Company and Eli Lilly Canada Inc., the makers and distributors of Zyprexa, for damages claiming $900,000,000.00. This action is similar to the one which has been brought in the Ontario Superior Court on behalf of all persons in Canada who were prescribed Zyprexa and who became diabetic as a result of taking that drug. The claim has been brought on behalf of the plaintiffs, John Douglas Helm and Margaret Lockwood who were each prescribed Zyprexa and both subsequently diagnosed as diabetic. It is alleged that the plaintiffs became diabetic as a result of having been prescribed Zyprexa. They are now under constant medical care. The lawyers for the plaintiff, Harvin Pitch, counsel to Stevensons Barristers, and Colin Stevenson intend to work with law firms across Canada and the United States in pursuing this claim and other similar claims against the manufacturers and distributors of Zyprexa, Eli Lilly & Company and Eli Lilly Canada Inc. A copy of the statement of claim can be seen on the following two websites: www.classproceedings.ca and www.zyprexacanadianclassaction.ca.